MicroRNA-631 deriving from bone marrow mesenchymal stem cell exosomes facilitates the malignant behavior of non-small cell lung cancer via modulating the E2F family of transcription factor 2/phosphatidylinositol 3‐kinase/Akt signaling pathway

References

• Schwartz A, Cote M. Epidemiology of lung cancer. Adv Exp Med Biol. 2016;893:21–41.
   PubMed Web of Science ®Google Scholar
• Bade B, Dela Cruz C. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41:1–24.
   PubMed Web of Science ®Google Scholar
• Thai A, Solomon B, Sequist L, et al. Lung cancer. Lancet. 2021; 398(10299):535–554.
   Web of Science ®Google Scholar
• Wang M, Herbst R, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27(8):1345–1356.
   PubMed Web of Science ®Google Scholar
• Wu H, Mu X, Liu L, et al. Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1. Cell Death Dis. 2020;11:801.
   PubMed Web of Science ®Google Scholar
• Lai R, Yeo R, Lim S. Mesenchymal stem cell exosomes. Semin Cell Dev Biol. 2015;40:82–88.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin C. Exosomes miR-22-3p derived from mesenchymal stem cells suppress colorectal cancer cell proliferation and invasion by regulating RAP2B and PI3K/AKT pathway. J Oncol. 2021;2021:3874478.
   PubMed Web of Science ®Google Scholar
• Zhang N, Li L, Luo J, et al. Inhibiting microRNA-424 in bone marrow mesenchymal stem cells-derived exosomes suppresses tumor growth in colorectal cancer by upregulating TGFBR3. Arch Biochem Biophys. 2021;709:108965.
   PubMed Web of Science ®Google Scholar
• Zhang C, Cao J, Lv W, et al. CircRNA_100395 carried by exosomes from adipose-derived mesenchymal stem cells inhibits the malignant transformation of non-small cell lung carcinoma through the miR-141-3p-LATS2 axis. Front Cell Dev Biol. 2021;9:663147.
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhang D, Li L, et al. Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2. Stem Cell Res Ther. 2020;11:87.
   PubMed Web of Science ®Google Scholar
• Lu T, Rothenberg M. MicroRNA. J Allergy Clin Immunol. 2018;141:1202–1207.
   PubMed Web of Science ®Google Scholar
• Correia de Sousa M, Gjorgjieva M, Dolicka D, et al. Deciphering miRNAs’ action through miRNA editing. Int J Mol Sci. 2019;20(24):6249.
   PubMed Web of Science ®Google Scholar
• Duan X, Qiao S, Li D, et al. Circulating miRNAs in serum as biomarkers for early diagnosis of non-small cell lung cancer. Front Genet. 2021;12:673926.
   PubMed Web of Science ®Google Scholar
• Yun L, Yue C, Cai Y. Circ_0067835 sponges miR-324-5p to induce HMGA1 expression in endometrial carcinoma cells.[J]. J Cell Mol Med. 2020;24:13927–13937.
   PubMed Web of Science ®Google Scholar
• Luan X, Wang Y. LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p. J Gynecol Oncol. 2018;29:e95.
   PubMed Web of Science ®Google Scholar
• Li H, Li F. Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p. Br J Cancer. 2018;119:744–755.
   PubMed Web of Science ®Google Scholar
• Fafián-Labora J, Morente-López M, Sánchez-Dopico M, et al. Influence of mesenchymal stem cell-derived extracellular vesicles in vitro and their role in ageing. Stem Cell Res Ther. 2020;11:13.
   PubMed Web of Science ®Google Scholar
• Wu Q, Ma J, Wei J, et al. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway. Mol Oncol. 2021;15:299–316.
   PubMed Web of Science ®Google Scholar
• Duan J, Yin Y, Cui J, et al. Chikusetsu Saponin IVa Ameliorates cerebral ischemia reperfusion injury in diabetic mice via adiponectin-mediated AMPK/GSK-3β pathway in vivo and in vitro. Mol Neurobiol. 2016;53:728–743.
   PubMed Web of Science ®Google Scholar
• Hongbo W, Xiaoqian M, Lei L, et al. Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1.[J]. Cell Death Dis. 2020;11:801.
   PubMed Web of Science ®Google Scholar
• Jonna S, Subramaniam D. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med. 2019;27:167–170.
   PubMed Web of Science ®Google Scholar
• Chen B, Liao Z, Qi Y, et al. miR-631 inhibits intrahepatic metastasis of hepatocellular carcinoma by targeting PTPRE. Front Oncol. 2020;10:565266.
   PubMed Web of Science ®Google Scholar
• Fu D, Liu B, Zang L, et al. MiR-631/ZAP70: a novel axis in the migration and invasion of prostate cancer cells. Biochem Biophys Res Commun. 2016;469:345–351.
   PubMed Web of Science ®Google Scholar
• Xi H, Li L, Du J, et al. hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10. Oncol Rep. 2017;37:961–968.
   PubMed Web of Science ®Google Scholar
• Chen L, Yu J, Lu Z, et al. E2F2 induction in related to cell proliferation and poor prognosis in non-small cell lung carcinoma. Int J Clin Exp Pathol. 2015;8:10545–10554.
   PubMed Web of Science ®Google Scholar
• Zhou X, Tao H. Overexpression of microRNA-936 suppresses non-small cell lung cancer cell proliferation and invasion via targeting E2F2. Exp Ther Med. 2018;16:2696–2702.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Z, Jiang H, et al. Circular RNA circPVT1 promotes proliferation and invasion through sponging miR-125b and activating E2F2 signaling in non-small cell lung cancer. Cell Physiol Biochem. 2018;51(5):2324–2340.
   PubMedGoogle Scholar
• Bai Q, Li L, Chen F, et al. Suppression of circular RNA Hsa_circ_0109320 attenuates non-small cell lung cancer progression via MiR-595/E2F7 axis. Med Sci Monit. 2020;26:e921200.
   PubMed Web of Science ®Google Scholar
• Li H, Zhao S, Shen L, et al. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer. Aging (Albany NY). 2021;13(10):13626–13643.
   PubMedGoogle Scholar
• Zhang L, Liu Z, Dong Y, et al. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner. Life Sci. 2021;276:119412.
   PubMed Web of Science ®Google Scholar
• Nikfarjam S, Rezaie J, Zolbanin N, et al. Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine. J Transl Med. 2020;18(1):449.
   PubMed Web of Science ®Google Scholar
• Vakhshiteh F, Atyabi F, Ostad S. Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy. Int J Nanomedicine. 2019;14:2847–2859.
   PubMed Web of Science ®Google Scholar
• Phinney D, Pittenger M. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851–858.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang C, Lin H, et al. microRNA-204 shuttled by mesenchymal stem cell-derived exosomes inhibits the migration and invasion of non-small-cell lung cancer cells via the KLF7/AKT/HIF-1α axis. Neoplasma. 2021;68(4):719–731.
   Web of Science ®Google Scholar